Skip to main content

Research

Dynamic Assessment of Pregnancies and Infants

Drive informed decisions about maternal and infant health with our claims-based research database.

Understanding maternal health outcomes

Critical to ensuring the well-being of both pregnant women and babies is an understanding of how various medications may affect them. Yet evidence can be difficult to find. Optum® Dynamic Assessment of Pregnancies and Infants (DAPI) links women and their infants’ health data to answer questions about maternal health.

The resulting database allows researchers to track women's exposures and the medications they took before and during pregnancy, then link those exposures to infants in utero. We examine these exposures in relation to pregnancy outcomes and infant health outcomes.

Linking women and their infant's health data

Our extensive database empowers patients and providers with critical decision-making tools.

Growing depth of data

Our database includes approximately 200,000 pregnancies per calendar year.

Help patients and providers make decisions

Tap into our connected claims and medical records databases to contribute to public health knowledge.

Support regulatory agencies

Meet regulatory standards and requests for drug labeling.

Pregnancy attributes

Discover data variables that may be of interest as we work together to address your study objectives.

Related healthcare insights

View all

Article

Using epidemiological data build public confidence

See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.

Guide

Informing FDA best initiative

As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.

E-book

The 6 trends shaping pharma strategies in 2024

Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.

Fill in the data gaps on medicine safety during pregnancy

Complementary solutions

Partner with Our Epidemiology Consultants

Advance public health and safety with our trusted experts and data.

Clinicogenomics for Greater Data Insights

Better understand diseases and drug development opportunities.

Strengthen your value story with HEOR

Tap into our expertise in health economics and outcomes research.